The primary focus in valve technology advancements is reliability, particularly in pharmaceutical applications where system integrity and contamination prevention are critical. Talking with the PharmTech Group at INTERPHEX 2025, Dave Loula, global product director, ITT Engineered Valves, emphasizes that customers seek valves that are easy to maintain and provide consistent performance. Key innovations in advanced sensing technologies are those that address customers’ need for reliable and easily maintained valves.
“The advanced sensing—we term this ‘Integrated Sensing Platform,’ our new ISP technology—is part of that reliability solution that the customers are looking for when they're looking for feedback on their valves. They want to make sure that they're getting a reliable sensing of the position of the valve so that they know that a valve is in the open position or in the closed position so they can go on and do their particular operation. The ISP, which is a very small, compact device that fits on top of one of our valves, provides that type of reliable feedback on valve operation,” Loula says.
ISP technology plays a crucial role in maintaining process integrity, reducing the risk of system failures, and ensuring compliance with stringent regulatory requirements. Additionally, the broader platform includes sensors, actuation systems, and advanced monitoring solutions to support end users, original equipment manufacturers, and distributors, Loula explains. Loula is most looking forward to engaging with industry stakeholders at INTERPHEX to foster collaboration and knowledge exchange.
He believes that such engagement ensures that emerging needs in pharmaceutical valve technology are met with cutting-edge solutions. Click above to view the full interview. Attendees can visit ITT at Booth #3337 at INTERPHEX 2025, being held in New York City on April 1–3.
Click here for more conference coverage. About the speaker David Loula, Global Product Director, ITT Engineered Valves David Loula has extensive experience in the biopharmaceuticaland industrial sectors, specializing in sales,product management, and business strategy. Currently serving as global product director and previously as global marketing manager at ITT Engineered Valves since August 2012, Loula has driven significant product initiatives and marketing strategies.
Prior roles include business development manager at ITT Industries and sales manager at ITT PureFlo, where he managed sales efforts for the Pure-Flo hygienic diaphragm valve product line across a 15-state region. Loula's educational background includes a Bachelor of Science in Mechanical Engineeringdegree from the University of Michigan..
Health
INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

Speaking with the PharmTech Group at INTERPHEX 2025, Dave Loula, global product director, ITT Engineered Valves, discusses innovation in advanced sensing technologies that addresses customer need for reliable valve function.